4//SEC Filing
Fenimore Christopher R. 4
Accession 0001883850-24-000045
CIK 0000872589other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:27 PM ET
Size
24.9 KB
Accession
0001883850-24-000045
Insider Transaction Report
Form 4
Fenimore Christopher R.
VP, Controller
Transactions
- Sale
Common Stock
2024-08-28$1204.79/sh−228$274,692→ 966 total(indirect: 2021 GRAT) - Sale
Common Stock
2024-08-28$1206.30/sh−200$241,260→ 0 total(indirect: 2021 GRAT) - Sale
Common Stock
2024-08-28$1205.67/sh−235$283,332→ 225 total(indirect: By Trust) - Sale
Common Stock
2024-08-28$1204.71/sh−2,237$2,694,936→ 1,378 total(indirect: 2022 GRAT) - Sale
Common Stock
2024-08-28$1205.49/sh−928$1,118,695→ 450 total(indirect: 2022 GRAT) - Sale
Common Stock
2024-08-28$1205.67/sh−236$284,538→ 225 total(indirect: By Trust) - Sale
Common Stock
2024-08-28$1206.70/sh−200$241,340→ 25 total(indirect: By Trust) - Sale
Common Stock
2024-08-28$1205.44/sh−766$923,367→ 200 total(indirect: 2021 GRAT) - Sale
Common Stock
2024-08-28$1206.67/sh−200$241,334→ 25 total(indirect: By Trust) - Sale
Common Stock
2024-08-28$1206.15/sh−450$542,768→ 0 total(indirect: 2022 GRAT)
Holdings
- 15,305
Common Stock
- 1,897(indirect: By Trust)
Common Stock
- 1,515(indirect: By 401(k))
Common Stock
Footnotes (11)
- [F1]Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F10]Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F11]These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- [F2]Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001697422
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:27 PM ET
- Size
- 24.9 KB